Natalie Franklin

Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease

Kevin J. Harrington, A. Berrier, Martin Robinson et al. · European Journal of Cancer · 2012 · 118 citations

Medicine, Oncology, Radiation Oncology +7

Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study

Kevin J. Harrington, Stéphane Temam, Hisham Mehanna et al. · Journal of Clinical Oncology · 2015 · 103 citations

Medicine, Oncology, Radiation Oncology +15

Geographic variation in human papillomavirus–related oropharyngeal cancer: Data from 4 multinational randomized trials

Hisham Mehanna, Natalie Franklin, Natalie Compton et al. · Head & Neck · 2016 · 62 citations · Full text

Medicine, Oncology, Cancer Epidemiology +13

Final analysis: A randomized, blinded, placebo (P)-controlled phase III study of adjuvant postoperative lapatinib (L) with concurrent chemotherapy and radiation therapy (CH-RT) in high-risk patients with squamous cell carcinoma of the head and neck (SCCHN).

Kevin J. Harrington, Stéphane Temam, Anil D′Cruz et al. · Journal of Clinical Oncology · 2014 · 26 citations

Medicine, Oncology, Radiation Oncology +17

Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays

Jonathan A. Lee, Paul Shinn, Susan Jaken et al. · PLoS ONE · 2015 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17